Financhill
Back

Brooklyn ImmunoTherapeutics Stock Predictions

Sell
17

BTX
Brooklyn ImmunoTherapeutics

Last Price:
0.51
Seasonality Move:
16.29%

7 Day Trial

ALL ACCESS PASS

$ 7

Brooklyn ImmunoTherapeutics Stock Forecast

  • Is Brooklyn ImmunoTherapeutics Stock Undervalued?
    The current Brooklyn ImmunoTherapeutics [BTX] share price is $0.49. The Score for BTX is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • BTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Brooklyn ImmunoTherapeutics Stock Go Up Next Year?

Data Unavailable

Brooklyn ImmunoTherapeutics Stock Rating

Data Unavailable

Brooklyn ImmunoTherapeutics Stock Price History

Is BTX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
brooklynitx.com

52-Week Data

52-Week High:
13.63
52-Week Low:
0.45

Prediction Charts

Market Cap:
28.33M
Price in USD:
0.49
Volume:
396.39K
Beta:
0.00

Technical Analysis

SMA50:
0.57
SMA100:
0.99
SMA200:
2.84
52-Wk Change:
-95.84%

Stock Predictions

  • Is Brooklyn ImmunoTherapeutics stock public?
    Yes, Brooklyn ImmunoTherapeutics is a publicly traded company.
  • What is the Brooklyn ImmunoTherapeutics stock quote today?
    The Brooklyn ImmunoTherapeutics stock price isĀ 0.49 USD today.
  • How to buy Brooklyn ImmunoTherapeutics stock online?
    You can buy Brooklyn ImmunoTherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jul-21 0.62 0.57 0.62 0.56
Jul-22 0.57 0.53 0.58 0.52
Jul-25 0.56 0.53 0.56 0.52
Jul-26 0.52 0.49 0.53 0.49
Jul-27 0.51 0.49 0.51 0.45
Jul-28 0.55 0.49 0.55 0.48
Jul-29 0.51 0.49 0.52 0.48
Aug-1 0.50 0.49 0.50 0.48
Aug-2 0.49 0.50 0.52 0.48
Aug-3 0.49 0.50 0.51 0.49
Aug-4 0.52 0.52 0.54 0.51
Aug-5 0.53 0.53 0.57 0.52
Aug-8 0.54 0.52 0.56 0.50
Aug-9 0.52 0.49 0.52 0.49

Brooklyn ImmunoTherapeutics Earnings

Data Unavailable

Brooklyn ImmunoTherapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.12 per share.

* Brooklyn ImmunoTherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.